I administered 2 units of rapid‑acting insulin and the capillary blood glucose is now 427 mg/dL; what should I do next?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 6, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Immediate Management of Persistent Hyperglycemia After 2 Units of Insulin

Administer an additional 2-4 units of rapid-acting insulin immediately and recheck capillary blood glucose in 1-2 hours, while simultaneously investigating the underlying cause of this severe hyperglycemia.

Critical Assessment Required NOW

Rule Out Diabetic Ketoacidosis

  • Check for ketones immediately (urine or blood) if this patient has type 1 diabetes or is insulin-dependent, especially if accompanied by nausea, vomiting, abdominal pain, or altered mental status 1
  • For blood glucose >300 mg/dL (16.7 mmol/L), check for ketosis in ALL patients 1
  • If ketonuria is present or ketonemia ≥0.5 mmol/L, suspect early ketoacidosis and call for immediate physician evaluation 1

Verify Insulin Potency and Administration

  • Inspect the insulin vial immediately for changes including clumping, frosting, precipitation, or change in clarity/color that may signify loss of potency 1
  • Confirm the insulin was administered correctly (proper dose drawn, injected subcutaneously, not intramuscularly) 1
  • Verify the insulin has not been exposed to extreme temperatures (<36°F or >86°F) and has been stored properly 1
  • If the vial has been in use >1 month, especially at room temperature, replace it with a new vial as potency may be compromised 1

Immediate Correction Dose Protocol

For Patients Already on Scheduled Insulin

  • Give 2 units of rapid-acting insulin for pre-meal glucose >250 mg/dL (13.9 mmol/L) 1
  • Give 4 units of rapid-acting insulin for pre-meal glucose >350 mg/dL (19.4 mmol/L) 1
  • At 427 mg/dL (23.7 mmol/L), this patient requires 4 units of rapid-acting insulin immediately 1

Calculate Individualized Correction Dose

  • Use the insulin sensitivity factor (ISF): ISF = 1500 ÷ Total Daily Dose (TDD) for regular insulin 2
  • Correction dose = (Current glucose - Target glucose) ÷ ISF 2
  • Example: If TDD is 30 units, ISF = 1500 ÷ 30 = 50 mg/dL per unit; correction = (427 - 125) ÷ 50 = 6 units 2

Critical Pitfall: This Patient Needs MORE Than Correction Insulin

The Fundamental Problem

  • A blood glucose of 427 mg/dL indicates complete inadequacy of the current insulin regimen - this is NOT just a correction dose situation 1
  • Sliding scale insulin as monotherapy is explicitly condemned by all major diabetes guidelines and shown to be ineffective 1
  • Only 38% of patients receiving sliding scale alone reach mean blood glucose <140 mg/dL, versus 68% with scheduled basal-bolus regimens 1

Immediate Regimen Change Required

  • Discontinue sliding scale insulin as the sole treatment immediately 1
  • Start a scheduled basal-bolus insulin regimen with:
    • Basal insulin: 0.3-0.5 units/kg/day for severe hyperglycemia, given as 50% of total daily dose 1, 2
    • Prandial insulin: Remaining 50% divided among three meals using rapid-acting insulin 1, 2
  • For a 70 kg patient with glucose 427 mg/dL, start with 21-35 units total daily (approximately 10-18 units basal + 3-6 units before each meal) 2

Monitoring and Follow-Up

Short-Term Monitoring (Next 2-4 Hours)

  • Recheck capillary blood glucose in 1-2 hours after correction dose 1
  • If glucose remains >300 mg/dL after 2 hours, give another correction dose and investigate further 1
  • Monitor for symptoms of hypoglycemia as glucose begins to fall 1

Ongoing Monitoring Requirements

  • Check capillary blood glucose before each meal and at bedtime once eating 3
  • Continue every 1-2 hours if NPO and receiving glucose-containing infusions 3
  • Daily fasting blood glucose monitoring is essential during titration 2

Address Foundation Therapy

Metformin Must Be Optimized

  • Continue or start metformin at maximum tolerated dose (up to 2000-2550 mg daily) unless contraindicated 2
  • Metformin reduces total insulin requirements and provides superior glycemic control when combined with insulin 2
  • Never discontinue metformin when starting or intensifying insulin therapy 2

Common Pitfalls to Avoid

  • Never rely solely on correction doses to manage persistent hyperglycemia - scheduled insulin doses must be established 1
  • Never delay transition to scheduled insulin when blood glucose values are consistently >250 mg/dL 1
  • Never give rapid-acting insulin at bedtime as a sole correction dose, as this markedly raises nocturnal hypoglycemia risk 1, 3
  • Never assume 2 units was adequate - this dose is far too small for glucose of 427 mg/dL and indicates fundamental under-dosing 1, 2

When to Escalate Care Immediately

  • If ketones are present (ketonuria ≥ trace or ketonemia ≥0.5 mmol/L) 1, 3
  • If patient has nausea, vomiting, abdominal pain, or altered mental status 1
  • If glucose remains >300 mg/dL despite two correction doses 1
  • If patient is unable to take oral fluids or shows signs of dehydration 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Initial Dosing for Lantus (Insulin Glargine) in Patients Requiring Insulin Therapy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Management of Pancreatectomy-Induced Diabetes (Type 3c)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.